Product How it works Pricing Blog FAQ About Contact
Korro Bio

Korro Bio (NASDAQ: KRRO) revenue

Korro Bio reported revenue of $6.4m for fiscal 2025, 181.5% more than in fiscal 2024 ($2.3m). Since fiscal 2019 its revenue has fallen by 77.9%, an average decline of 22.3% a year.

Korro Bio's best year of the last 7 was fiscal 2020. The biggest drop was in fiscal 2021, −62.0%.

Revenue, in millions of US dollars28.9201937.0202014.120210.020220.020232.320246.42025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$6.4m+181.5%−$121.9m−1,906.4%
2024$2.3m—−$91.9m−4,047.1%
2023$0.0m—−$84.5m—
2022$0.0m−100.0%−$59.0m—
2021$14.1m−62.0%−$84.0m−597.3%
2020$37.0m+27.8%−$27.6m−74.5%
2019$28.9m—−$20.7m−71.4%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Korro Bio revenue compared with its sector

By revenue for its latest fiscal year, Korro Bio ranks 379th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Korro Bio, 181.5%.

RankCompanyRevenueRevenue growth
377thWhitehawk Therapeutics$7.1m−72.5%
378thImmunome$6.9m−23.2%
379thKorro Bio$6.4m181.5%
380thAbeona Therapeutics$5.8m37.1%
381stLucid Diagnostics$4.7m8.3%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Korro Bio

How much revenue did Korro Bio make in fiscal 2025?
Korro Bio reported revenue of $6.4m for fiscal 2025, compared with $2.3m in fiscal 2024.
How much has the revenue of Korro Bio fallen?
Between fiscal 2019 and fiscal 2025 it went from $28.9m to $6.4m: 77.9% less, an average decline of 22.3% a year.
What was the best year for revenue at Korro Bio?
Of its last 7 fiscal years, fiscal 2020, with $37.0m.
Where does Korro Bio rank in its sector by revenue?
It ranks 379th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Korro Bio come from?
From the annual report (Form 10-K) that Korro Bio files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Korro Bio files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Korro Bio: the Korro Bio page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.